Fonte: The FASEB Journal. Unidades: FMRP, FCFRP
Assuntos: ARTRITE REUMATOIDE, DIFERENCIAÇÃO CELULAR, INFLAMAÇÃO, INTERLEUCINAS, ARTICULAÇÕES, NEUTRÓFILOS, FATORES DE TRANSCRIÇÃO
ABNT
PRADO, Douglas Silva et al. NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation. The FASEB Journal, v. 34, n. 8, p. 10907-10919, 2020Tradução . . Disponível em: https://doi.org/10.1096/fj.202000795R. Acesso em: 23 ago. 2024.APA
Prado, D. S., Veras, F. P., Ferreira, R. G., Damasceno, L. E. A., Melo, P. H., Zamboni, D. S., et al. (2020). NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation. The FASEB Journal, 34( 8), 10907-10919. doi:10.1096/fj.202000795RNLM
Prado DS, Veras FP, Ferreira RG, Damasceno LEA, Melo PH, Zamboni DS, Cunha TM, Cunha FQ, Alves Filho JCF. NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation [Internet]. The FASEB Journal. 2020 ; 34( 8): 10907-10919.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1096/fj.202000795RVancouver
Prado DS, Veras FP, Ferreira RG, Damasceno LEA, Melo PH, Zamboni DS, Cunha TM, Cunha FQ, Alves Filho JCF. NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation [Internet]. The FASEB Journal. 2020 ; 34( 8): 10907-10919.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1096/fj.202000795R